ECC-0509

N/A

Report date: 2025/10/20 14:18:40
NME

Base Information

Drug NameECC-0509
Drug Alias NameECC-0509
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmine oxidase, copper containing inhibitors
TargetsAmine oxidase, copper containing
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEccogene (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEccogene (Shanghai) Co LtdSyneos Health
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A